Drug interactions in prescriptions from selected Indian community pharmacies [9]

Journal of Pharmacy Practice and Research

Volumn 35, Issue 4, 2005, Pages 332-

  Nagavi, B G ^a   Adepu, Ramesh ^a   Singhal, Rohit ^b  

^a JSS COLLEGE OF PHARMACY   (India)

^b Lachoo Memorial College of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIPYRETIC AGENT; ANTITHROMBOCYTIC AGENT; BRONCHODILATING AGENT; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; TUBERCULOSTATIC AGENT;

AGE; COMMUNITY CARE; COMORBIDITY; CONTINUING EDUCATION; DRUG CLASSIFICATION; DRUG INTERACTION; DRUG USE; HUMAN; INCIDENCE; INDIA; LETTER; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHARMACIST; PHARMACY; POLYPHARMACY; PRESCRIPTION;

EID: 32644439875     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Weideman RA, McKinney WP, Bernstein IH. Predictors of potential drug interactions. Hosp Pharm 1998; 33: 835-40.
2. Bergendal L, Friberg A, Scheffrath AM. Potential drug-drug interactions in 5125 mostly elderly outpatients in Gothenburg, Sweden. Pharm World Sci 1995; 17: 152-7.
3. Tamal I, Strome LS, Marshall CE, Mooradian AD. Analysis of drug-drug interactions in nursing home residents. Am J Hosp Pharm 1989; 46: 1567-9.
4. Jankel CA, McMillan JA, Martin BC. Effect of drug interactions on outcomes of patient receiving warfarin or theophylline. Am J Hosp Pharm 1994; 51: 661-6.
5. Lien LL, Lien EJ. Preventing potential drug interactions in community pharmacy. J Clin Pharm Ther 1994; 19: 371-9.
6. Anonymous. Drug interaction facts on disc. Facts & comparisons. St Louis: Wolter Kluwer Company; 2003.
7. Stockley IH, editor. Drug interactions. 6th ed. London: Pharmaceutical Press; 2002.